Risk Sharing​: Success, Failures & What Comes Next​

At the Pharma Pricing & Access Innovation Conference (PPIC), Dr. Daniel Parle, Access and Contracting Strategy Lead at Lyfegen, examined the steady rise of risk-sharing agreements in response to mounting pressure on health budgets, high-cost innovative therapies, and increasing demands for real-world evidence.

The session explores how budget uncertainty, clinical uncertainty, and value uncertainty are reshaping contracting structures across markets. Drawing on real-world examples, it highlights common structural pitfalls, where agreements tend to break down, and what differentiates sustainable models from those that fail under operational strain.

Access the full presentation to explore practical lessons for designing risk-sharing and innovative agreements that are robust, scalable, and built to hold up in practice.

‍